IP Library Assignment 064721/0849
Patent Assignment
Reel/Frame 064721/0849

Assignment of Assignor's Interest

Recorded: 2023-08-28 Pages: 7
Assignor
PORTER, RODERICK
Executed: 2023-03-14
Assignee
OREXIA THERAPEUTICS LIMITED
24 CHISWELL STREET, LONDON, EC1Y 4YX, UNITED KINGDOM
Covered Properties (2)
Bicyclic-Heterocycle Derivatives and Related Uses
Bicyclic-Heterocycle Derivatives and Their Uses as Orexin-2 Receptor Agonists
Application: 18/024,216 →
Publication: US 2023/0271973
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 28, 2023
From: LEFKER, BRUCE
To: OREXIA THERAPEUTICS LIMITED
Reel/Frame 064721/0738 →
Assignment of Assignor's Interest Aug 28, 2023
From: HUMPHRIES, PAUL
To: OREXIA THERAPEUTICS LIMITED
Reel/Frame 064721/0767 →
Assignment of Assignor's Interest Aug 28, 2023
From: GIBSON, KARL
To: OREXIA THERAPEUTICS LIMITED
Reel/Frame 064721/0781 →
Assignment of Assignor's Interest Aug 28, 2023
From: SPENDIFF, MATTHEW; BUCKNELL, SARAH; ZAWODNY, WOJCIECH
To: OREXIA THERAPEUTICS LIMITED
Reel/Frame 064721/0819 →
Assignment of Assignor's Interest Oct 20, 2023
From: OREXIA THERAPEUTICS LIMITED
To: CENTESSA PHARMACEUTICALS (UK) LIMITED
Reel/Frame 065300/0110 →
Security Interest Dec 31, 2024
From: CENTESSA PHARMACEUTICALS (UK) LIMITED
To: OXFORD FINANCE LLC
Reel/Frame 069708/0039 →
Change of Name Jul 10, 2025
From: OREXIA THERAPEUTICS LIMITED
To: CENTESSA PHARMACEUTICALS (OREXIA) LIMITED
Reel/Frame 071665/0741 →
Release of Security Interest Jun 24, 2026
From: OXFORD FINANCE LLC
To: CENTESSA PHARMACEUTICALS (UK) LIMITED
Reel/Frame 075069/0879 →